Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Hepatology

• Publication date

  1997-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(97)80436-9PMID 9075678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats.

  1996cited by this paper
• Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats.

  1996cited by this paper
• Selective inhibition of inducible nitric oxide synthase by aminoguanidine.

  1996cited by this paper
• The role of inducible no synthase (iNOS) in the hyperdynamic circulation of portal hypertension

  1995cited by this paper
• Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

  1995cited by this paper
• Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo.

  1995cited by this paper
• Gastric microcirculatory changes of Portal‐hypertensive rats can be attenuated by long‐term Estrogen‐progestagen treatment

  1994cited by this paper
• Nω‐Nitro‐L‐arginine Administration Corrects Peripheral Vasodilation and Systemic Capillary Hypotension and Ameliorates Plasma Volume Expansion and Sodium Retention in Portal Hypertensive Rats

  1993cited by this paper
• Aminoguanidine selectively inhibits inducible nitric oxide synthase

  1993cited by this paper
• Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

  1993cited by this paper
• N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats.

  1993cited by this paper
• Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal‐hypertensive anesthetized rats

  1993cited by this paper
• Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension

  1993cited by this paper
• Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

  1993cited by this paper
• Administration of Nω-nitro-l-arginine ameliorates portal-systemic shunting in portal-hypertensive rats

  1993cited by this paper
• Vasodilatation and sodium retention in prehepatic portal hypertension.

  1992cited by this paper
• Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats.

  1992cited by this paper
• In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade.

  1992cited by this paper
• Evidence for normal nitric oxide—mediated vasodilator tone in conscious rats with cirrhosis

  1992cited by this paper
• Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.

  1992cited by this paper
• The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats

  1992cited by this paper
• Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension

  1992cited by this paper
• Sequence of morphological and hemodynamic changes of gastric microvessels in portal hypertension.

  1992cited by this paper
• Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

  1991cited by this paper
• Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital.

  1990cited by this paper
• Autoradiographic study of the regional distribution of gastric blood flow in portal hypertensive rats.

  1989cited by this paper
• Gastric mucosal blood flow and acid secretion in portal hypertensive rats.

  1988cited by this paper
• Gastric vascular changes in portal hypertension

  1988cited by this paper
• Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I.

  1987cited by this paper
• Splanchnic Hemodynamics in Chronic Portal Hypertension

  1986cited by this paper
• Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

  1985cited by this paper
• Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.

  1985cited by this paper
• Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.

  1983cited by this paper
• Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis.

  1982cited by this paper
• Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

  1981cited by this paper

• Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats

  2019cites this paper
• Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center

  2017cites this paper
• The beneficial effects of curcumin in cirrhotic rats with portal hypertension

  2017cites this paper
• The Possible Role of Nitric Oxide and Oxidative Stress in the Enhanced Apoptosis of Cardiac Cells in Cirrhotic Rats.

  2017cites this paper
• Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

  2016cites this paper
• Full Length Research Article A NOVEL ANTIANXIETY - LIKE ACTIVITY OF AMINO GUANIDINE IN STRESSED MICE: EVIDENCE OF REGULATION BY NO: CGMP MODULATION

  2015cites this paper
• The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis

  2015cites this paper
• Gastroenteropatía por hipertensión portal: prevalencia y factores predictivos, utilidad de los métodos diagnósticos y determinación de los niveles plasmáticos de factores angiogénicos

  2015cites this paper
• NON – RECEPTOR MEDIATED ANXIOLYSIS BY AMINO GUANIDINE: A NOVEL ACTIVITY AND SYNERGY WITH DIAZEPAM UNDER STRESSED CONDITIONS

  2015cites this paper
• Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.

  2014cites this paper
• Effect of Biliary Cirrhosis on Neurogenic Relaxation of Rat Gastric Fundus and Anococcygeus Muscle: Role of Nitric Oxide Pathway

  2014cites this paper
• Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.

  2013cites this paper
• Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: The role of nitric oxide and IL-1β

  2013cites this paper
• Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats

  2013cites this paper
• The Roles of Angiotensin II Receptors in the Portosystemic Collaterals of Portal Hypertensive and Cirrhotic Rats

  2012cites this paper
• Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats

  2012cites this paper
• Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.

  2011cites this paper
• Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure

  2010cites this paper
• Simvastatin effects on portal‐systemic collaterals of portal hypertensive rats

  2009cites this paper
• The Journal of Tehran University Heart Center (87-01-19).indd

  2008cites this paper
• Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms

  2007cites this paper
• Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

  2006cites this paper
• Lanreotide on Collateral Response to Endothelin‐1 and Vasopressin in Cirrhotic Rats

  2006cites this paper
• Methimazole Alleviates Hepatic Encephalopathy in Bile‐duct Ligated Cirrhotic Rats

  2006cites this paper
• Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive rats

  2006cites this paper
• Role of vascular nitric oxide in experimental liver cirrhosis.

  2005cites this paper
• Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.

  2004cites this paper
• Lack of detrimental effects of nitric oxide inhibition in bile duct‐ligated rats with hepatic encephalopathy

  2004cites this paper
• Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.

  2004cites this paper
• Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats

  2003cites this paper
• Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension.

  2003cites this paper
• [Role of vascular nitric oxide in experimental liver cirrhosis].

  2002cites this paper
• Effects of somatostatin and octreotide on portal-systemic collaterals in portal hypertensive rats.

  2002cites this paper
• [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].

  2001cites this paper
• Nitric oxide and cirrhosis of the liver

  2001cites this paper
• Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome

  2001cites this paper
• Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistula.

  2000cites this paper
• Chronic Inhibition of Nitric Oxide Ameliorates Splanchnic Hyposensitivity to Glypressin in a Hemorrhage-transfused Rat Model of Portal Hypertension

  2000cites this paper
• Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.

  2000cites this paper
• Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.

  1998cites this paper
• Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.

  1998cites this paper
• Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.

  1997cites this paper
• Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide.

  1997cites this paper
• Hyperdynamic circulation of cirrhotic rats: role of substance P and its relationship to nitric oxide.

  1997cites this paper
• The role of nitric oxide in portal hypertensive systemic and portal vascular pathology.

  1997cites this paper
• Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with left adrenal vein ligation.

  1997cites this paper